IL160363A0 - Expandable gastric retention device - Google Patents
Expandable gastric retention deviceInfo
- Publication number
- IL160363A0 IL160363A0 IL16036301A IL16036301A IL160363A0 IL 160363 A0 IL160363 A0 IL 160363A0 IL 16036301 A IL16036301 A IL 16036301A IL 16036301 A IL16036301 A IL 16036301A IL 160363 A0 IL160363 A0 IL 160363A0
- Authority
- IL
- Israel
- Prior art keywords
- retention device
- gastric retention
- expandable gastric
- expandable
- retention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Jellies, Jams, And Syrups (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31307801P | 2001-08-16 | 2001-08-16 | |
PCT/US2001/046146 WO2003015745A1 (en) | 2001-08-16 | 2001-10-22 | Expandable gastric retention device |
Publications (1)
Publication Number | Publication Date |
---|---|
IL160363A0 true IL160363A0 (en) | 2004-07-25 |
Family
ID=23214285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16036301A IL160363A0 (en) | 2001-08-16 | 2001-10-22 | Expandable gastric retention device |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1416914A1 (en) |
JP (1) | JP2005501097A (en) |
KR (1) | KR20040032918A (en) |
CN (1) | CN1543337A (en) |
BR (1) | BR0117123A (en) |
CA (1) | CA2456976A1 (en) |
CO (1) | CO5670360A2 (en) |
IL (1) | IL160363A0 (en) |
MX (1) | MXPA04001388A (en) |
NO (1) | NO20040611L (en) |
NZ (1) | NZ531461A (en) |
PL (1) | PL368327A1 (en) |
WO (1) | WO2003015745A1 (en) |
ZA (1) | ZA200402066B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003045308A2 (en) | 2001-11-21 | 2003-06-05 | E-Z-Em, Inc. | Formulations for use in medical or diagnostic procedures |
CA2550983C (en) * | 2003-12-24 | 2013-09-17 | Advancis Pharmaceutical Corporation | Enhanced absorption of modified release dosage forms |
US7785291B2 (en) | 2005-03-01 | 2010-08-31 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
US7699863B2 (en) | 2005-03-01 | 2010-04-20 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
KR20090053783A (en) * | 2006-07-19 | 2009-05-27 | 스미스클라인 비참 코포레이션 | Method for radiolabeling formulations for gamma scintigraphy assesment |
CN102552103B (en) * | 2010-12-20 | 2013-11-20 | 西安力邦医药科技有限责任公司 | Lamivudine solid dispersion, and preparation method, pharmaceutical composition and use of the dispersion |
US10507127B2 (en) | 2012-06-07 | 2019-12-17 | Epitomee Medical Ltd. | Expandable device |
EP3091962B1 (en) | 2013-12-05 | 2022-06-08 | Epitomee Medical Ltd. | Retentive devices and systems for in-situ release of pharmaceutical active agents |
EP3725357A1 (en) | 2014-06-11 | 2020-10-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
WO2016178971A1 (en) | 2015-05-01 | 2016-11-10 | Massachusetts Institute Of Technology | Triggerable shape memory induction devices |
AU2016342374B2 (en) | 2015-10-23 | 2022-08-04 | Lyndra Therapeutics, Inc. | Gastric residence systems for sustained release of therapeutic agents and methods of use thereof |
KR20180090881A (en) | 2015-12-08 | 2018-08-13 | 린드라 인코퍼레이티드 | Geometric configuration for the above stay system |
AU2017268840B2 (en) | 2016-05-27 | 2022-02-10 | Lyndra Therapeutics, Inc. | Materials architecture for gastric residence systems |
AU2017336154B2 (en) | 2016-09-30 | 2023-11-09 | Lyndra Therapeutics, Inc. | Gastric residence systems for sustained delivery of adamantane-class drugs |
WO2018227147A1 (en) | 2017-06-09 | 2018-12-13 | Lyndra, Inc. | Gastric residence systems with release rate-modulating films |
US11337919B2 (en) * | 2017-12-18 | 2022-05-24 | Tris Pharma, Inc. | Modified release drug powder composition comprising gastro-retentive RAFT forming systems having trigger pulse drug release |
TR201914116A2 (en) * | 2019-09-17 | 2021-04-21 | Univ Yeditepe | PRODUCTION METHOD OF NATURAL BIOMATERIALS AND CRYOGELS AND THE USE OF THESE CRYOGELS AS SOFT TISSUE SCACHE OR DRUG CARRIER SYSTEM |
WO2022195476A1 (en) | 2021-03-15 | 2022-09-22 | Clexio Biosciences Ltd. | Gastroretentive devices for assessment of intragastric conditions |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4764380A (en) * | 1982-03-22 | 1988-08-16 | Alza Corporation | Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills |
US5232704A (en) * | 1990-12-19 | 1993-08-03 | G. D. Searle & Co. | Sustained release, bilayer buoyant dosage form |
DE4406424A1 (en) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandable dosage forms |
ES2234139T3 (en) * | 1997-08-11 | 2005-06-16 | Alza Corporation | DOSAGE FORM OF AN ACTIVE PROLONGED RELEASE AGENT ADAPTED FOR GASTRIC RETENTION. |
EA004443B1 (en) * | 1998-09-14 | 2004-04-29 | Рэнбакси Лабораториз Лимитед | Pharmaceutical formulation for controlled release of ciprofloxacin for one administration per day |
JP2000256216A (en) * | 1999-03-04 | 2000-09-19 | Meiji Milk Prod Co Ltd | Gel composition |
HUP0301465A3 (en) * | 2000-06-23 | 2006-07-28 | Teva Pharma | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
-
2001
- 2001-10-22 JP JP2003520705A patent/JP2005501097A/en not_active Withdrawn
- 2001-10-22 BR BR0117123-2A patent/BR0117123A/en not_active IP Right Cessation
- 2001-10-22 CA CA002456976A patent/CA2456976A1/en not_active Abandoned
- 2001-10-22 NZ NZ531461A patent/NZ531461A/en unknown
- 2001-10-22 IL IL16036301A patent/IL160363A0/en unknown
- 2001-10-22 PL PL01368327A patent/PL368327A1/en not_active Application Discontinuation
- 2001-10-22 KR KR10-2004-7002254A patent/KR20040032918A/en not_active Application Discontinuation
- 2001-10-22 MX MXPA04001388A patent/MXPA04001388A/en not_active Application Discontinuation
- 2001-10-22 WO PCT/US2001/046146 patent/WO2003015745A1/en active Application Filing
- 2001-10-22 CN CNA018235441A patent/CN1543337A/en active Pending
- 2001-10-22 EP EP01995328A patent/EP1416914A1/en not_active Withdrawn
-
2004
- 2004-02-11 NO NO20040611A patent/NO20040611L/en not_active Application Discontinuation
- 2004-03-12 CO CO04023075A patent/CO5670360A2/en not_active Application Discontinuation
- 2004-03-15 ZA ZA200402066A patent/ZA200402066B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2005501097A (en) | 2005-01-13 |
MXPA04001388A (en) | 2004-05-27 |
CN1543337A (en) | 2004-11-03 |
BR0117123A (en) | 2004-09-28 |
NZ531461A (en) | 2008-03-28 |
WO2003015745A1 (en) | 2003-02-27 |
PL368327A1 (en) | 2005-03-21 |
ZA200402066B (en) | 2005-05-09 |
NO20040611L (en) | 2004-04-16 |
CO5670360A2 (en) | 2006-08-31 |
CA2456976A1 (en) | 2003-02-27 |
EP1416914A1 (en) | 2004-05-12 |
KR20040032918A (en) | 2004-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1070532A1 (en) | Expandable in-ear device | |
GB0114659D0 (en) | Device | |
IL160363A0 (en) | Expandable gastric retention device | |
GB0107858D0 (en) | Device | |
SG101984A1 (en) | Deplexer device | |
EP1379079A4 (en) | Contour-emphasizing device | |
GB2371229B (en) | De-odourising device | |
GB2376781B (en) | Memory device | |
GB0111329D0 (en) | Device | |
GB0111328D0 (en) | Device | |
GB0202445D0 (en) | Device | |
GB0111336D0 (en) | Device | |
GB2376720B (en) | Fluid-propelling device | |
GB2378421B (en) | Multi-embossing device | |
GB0111337D0 (en) | Device | |
GB0110166D0 (en) | Shock-shower device | |
GB0111330D0 (en) | Device | |
GB0114945D0 (en) | Device | |
GB2383317B (en) | Mooring device | |
GB0104001D0 (en) | Gastric drainage device | |
GB0116785D0 (en) | Mediical Device | |
TW461332U (en) | Leg-lifting device | |
GB0112011D0 (en) | Memory Device | |
GB0117190D0 (en) | Memory device | |
AU146292S (en) | Anchoring device |